MedTrace Logo

Platelet Rich Plasma for Insufficient Endometrium

NCT05538338 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2025-02-07

No results posted yet for this study

Summary

To determine the effectiveness of an intrauterine PRP infusion on endometrial thickness and in vitro fertilization (IVF) outcomes in a population of infertile women with a history of unresponsive thin endometrium.

Conditions

  • Infertility of Uterine Origin

Interventions

OTHER

Platelet Rich Plasma Intrauterine infusion

an intrauterine infusion of platelet rich plasma (PRP) will be administered to this group of participants

OTHER

Normal saline Intrauterine infusion

an intrauterine infusion of normal saline will be administered to this group of participants

Sponsors & Collaborators

  • Reproductive Medicine Associates of New Jersey

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-15
Primary Completion
2025-10-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05538338 on ClinicalTrials.gov